iReprogram
Dr. Roger Newton is the co-inventor of Lipitor, the most prescribed cholesterol-reducing drug in the world. As President and CEO of Espirion Therapeutics, he led the company to a $1.3B acquisition in 2004. He has worked for over thirty years in the pharmaceutical and biotech life sciences industries. He is currently Executive Chairman and CSO, and most recently, Founder, President/CEO, and Director of Esperion Therapeutics, Inc.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
iReprogram
iReprogram is a cell regeneration lab that aims to expedite the delivery of next-generation personalized medicine.